2022 Biological License Application Approvals
This list reflects information regarding the applications as of the approval date. It is not updated with regard to applicant or application status changes. The applications are listed by date of approval in reverse chronological order.
| Tradename/Proper Name | Indication for Use | STN | Manufacturer/ License Number |
Approval Date |
|---|---|---|---|---|
| PRIORIX Measles, Mumps and Rubella Vaccine Live |
Indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older. | 125748/0 | GlaxoSmithKline Biologicals SA 1250 South Collegeville Road Collegeville, PA 19426 Lic. # 1617 |
06/03/2022 |
| DG Gel 8 Direct Coombs (Anti-IgG, -C3d) Anti-Human Globulin (Rabbit/Murine Monoclonal) |
Indicated for use with the DG Gel System to detect in vivo coating of human red blood cells with IgG and C3d (direct antiglobulin test). | 125705/0 | Diagnostic Grifols, S.A. Avda. de la Gerneralitat, 152 Sant Cugat del Valles Barcelona 08174 Spain Lic. # 1887 |
05/20/2022 |
| Anti-Human Globulin Anti-C3d FFMU, Murine Monoclonal Anti-Human Globulin (Murine Monoclonal) (For Further Manufacturing Use) |
Indicated for further manufacturing use in the production of Anti-IgG, -C3d Anti-Human Globulin under a Shared Manufacturing Agreement with Diagnostic Grifols, S.A. | 125707/0 | Diagast NAMSA 400 Highway 169 South, Suite 500 Minneapolis, MN 55426 Lic. # 1744 |
05/20/2022 |
| Anti-Human Globulin Anti-C3d FFMU, Murine Monoclonal Anti-Human Globulin (Murine Monoclonal) (For Further Manufacturing Use) |
Indicated for further manufacturing use in the production of Anti-IgG, -C3d Anti-Human Globulin under a Shared Manufacturing Agreement with Diagnostic Grifols, S.A. | 125708/0 | Diagast NAMSA 400 Highway 169 South, Suite 500 Minneapolis, MN 55426 Lic. # 1744 |
05/20/2022 |
| DG Gel 8 Direct Coombs (Anti-C3d) Anti-Human Globulin (Murine Monoclonal) |
Indicated for use with the DG Gel System to detect in vivo coating of human red blood cells with C3d (direct antiglobulin test). | 125711/0 | Diagnostic Grifols, S.A. Avda. de la Gerneralitat, 152 Sant Cugat del Valles Barcelona 08174 Spain Lic. # 1887 |
05/20/2022 |
| CARVYKTI ciltacabtagene autoleucel |
Is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. | 125746/0 | Janssen Biotech, Inc. 920 US Highway 202 P.O. Box 300 Raritan, NJ 08869 Lic. # 1864 |
02/28/2022 |
| SPIKEVAX COVID-19 Vaccine, mRNA |
Active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older | 125752/0 | ModernaTX, Inc. 200 Technology Square Cambridge, MA 02139 Lic. # 2256 |
01/31/2022 |